You must log in to view this page.

SAB Biotherapeutics Inc.

NASDAQ: SABS
Share price (8/15/25): $2.22
Market cap (8/15/25): $23.1 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

Prospectuses and Registrations Filter

Exempt offering of securities

Registration of securities for employees

Registration of securities for employees

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

Sessa Capital IM, L.P., Sessa Capital (Master), L.P., Sessa Capital GP, LLC, Sessa Capital IM GP, LLC, Petry John

Kropotova Alexandra

Rtw Investments, LP

Kropotova Alexandra

News Filter

BIO Announces Oversubscribed $175 Million Private Placement

Shareholder Vote Results

Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements or Exhibits

BIO Announces Positive Topline Phase 1 Clinical Results With Potentially Disease-Modifying T1D Therapy SAB-142

BIO Provides SAB-142 Clinical Trial Progress Update at the European Association for the Study of Diabetes Annual Meeting

Proxies Filter

Definitive proxy

Definitive proxy

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC